MK-0608
CAS: 443642-29-3
Ref. TM-T16088
| 1mg | 80.00 € | ||
| 2mg | 94.00 € | ||
| 5mg | 172.00 € | ||
| 10mg | 270.00 € | ||
| 25mg | 515.00 € | ||
| 50mg | 737.00 € | ||
| 100mg | 1,012.00 € | ||
| 1ml*10 (DMSO) | 180.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Product Information
Name:
MK-0608
Synonyms:
- MK0608
- 7-(2-C-Methyl-β-<span class="text-smallcaps">D</span>-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 7-Deaza-2'-C-methyladenosine
- 7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-(2-C-methyl-beta-D-ribofuranosyl)-
- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(2-C-methyl-β-<span class="text-smallcaps">D</span>-ribofuranosyl)-
- Lamevudine
- Mk 0608
CAS:
Description:
MK-0608 is an orally bioavailable HCV replication inhibitor in vitro(EC50 = 0.3 μM and EC90=1.3 μM in the subgenomic-replicon assay).
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
280.28
Formula:
C12H16N4O4
Purity:
99.42%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T16088 MK-0608
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
